Study | Population | Comparison groups | Intervention | Outcomes | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Authors (year) | Animal model strain, sex, weight, age | OA induction | (number) | Dose of PRP | Treatment protocol | Variable | Tool | Statistical results | p-value | Effect size (95% confidence interval) |
Ahmad et al. (2020) | Rat Sprague Dawley N/A 400–550 g 4–5 mo. | Anterior cruciate ligament transection and Medial Meniscectomy | CG (10) PRP Group (10) | 1 mL of PRP | Single injection | Inflammatory markers (TNF-α levels) Inflammatory markers (IL-6 levels) Molecular markers (COL2 levels) Molecular markers (proteoglycans) Cartilage histology, Mankin Score | ELISA ELISA N/A Semi-quantitative analysis N/A | + + + + = | p = 0.039 p = 0.003 p = 0.12 p = 0.035 p > 0.05 | 2.45 (4.87 to 10.93) 5.09 (26.42 to 38.38) N/A 2.55 (−9.17 to −4.23) 0.95 (0.01 to 2.19) |
Almasry et al. (2014) | Albino rat Wistar 25 ♂ 250–350 g Adult | Medial Meniscectomy | CG (12) PRP Group (13) | 0.085 mL of PRP | 3x/wk. for 2 wk. | Molecular markers (PDGF-A levels) Molecular markers (VEGF-A levels) Molecular markers (PDGF-A localization) Molecular markers (VEGF-A localization) Cartilage histology (Matrix loss) Cartilage histology (Degeneration) Cartilage histology (Zonal depth ratio of lesions) Cartilage histology (Total degeneration width) Cartilage histology (Significant degeneration width) Cartilage histology (Osteophyte) Cartilage histology (Medial capsule width) Cartilage histology (Subchondral bone damage) Synovium histology (Synovial reaction) | ELISA ELISA Quantitative analysis Quantitative analysis Modified OARSI Score Modified OARSI Score Modified OARSI Score Modified OARSI Score Modified OARSI Score Modified OARSI Score Modified OARSI Score Modified OARSI Score Modified OARSI Score | + + + + + + + + + + + + + | p < 0.001 p < 0.001 p = 0. 007 p = 0. 002 p = 0.001 p < 0.001 p < 0.001 p < 0.001 p = 0.001 p = 0.041 p < 0.001 p < 0.001 p < 0.003 | 6.43 (22.04 to 28.56) 14.97 (43.64 to 48.76) 4.89 (7.92 to 11.16) 5.67 (6.46 to 8.72) −7.44 (−618.41 to −464.54) N/A −9.00 (−0.98 to −0.82) −8.75 (−673.87 to −555.13) −7.23 (−460.29 to −375.71) N/A −7.51 (−105.47 to −84.53) N/A N/A |
Arican et al. (2018) | Dog Mixed breed N/A 25–50 kg 8–10 yr. | Naturally occurring | CG (6) PRP Group (14) | 4–5 mL of PRP | Single injection | Molecular markers (MMP-2) Molecular markers (MMP-9) | ELISA ELISA | = + | p > 0.05 p < 0.05 | N/A N/A |
Asjid et al. (2018) | Rat Sprague Dawley N/A 200–300 g 3–4 mo. | MIA injection | CG (8) PRP Group (8) | 0.5 mL of PRP | Single injection | Cartilage histology | Mankin Score | + | p = 0.003 | −1.78 (−3.20 to −0.80) |
Chouhan et al. (2019) | Guinea pig Dunkin-Hartley N/A 600–800 g 5 mo. | Naturally occurring | CG A (5) CG B (5) S. PRP Group A (5) M. PRP Group A (6) S. PRP Group B (5) M. PRP Group B (6) | Unclear | Single injection (S) 1x/wk. for 3 wk. (M) | CG A Vs. S. PRP Group A Synovium histology Cartilage histology CG A Vs. M. PRP Group A Synovium histology Cartilage histology CG B Vs. S. PRP Group B Synovium histology Cartilage histology CG B Vs. M. PRP Group B Synovium histology Cartilage histology | Pelletier Score Mankin Score Pelletier Score Mankin Score Pelletier Score Mankin Score Pelletier Score Mankin Score | + = + = + = + = | p = 0.011 p = 0.442 p = 0.002 p = 0.005 p = 0.562 p ≥ 0.999 p = 0.000 p = 0.146 | −0.19 (−3.46 to 2.66) 0.08 (−3.66 to 4.06) -0.46 (−4.8 to 2.40) -0.90 (−6.14 to 1.28) 1.54 (0.11 to 4.29) 1.42 (−0.13 to 8.93) -0.01 (−3.15 to 3.09) 0.43 (−1.26 to 2.40) |
Coskun et al. (2018) | Rabbit New Zealand 32 ♂ 3–3,5 kg Adult | MIA injection | S. CG (8) M. CG (8) S. PRP Group (8) M. PRP Group (8) | 0.8–1 mL of PRP | Single injection (S) 1x/wk. for 3 wk. (M) | S. CG Vs. S. PRP Group Cartilage histology (Cartilage structure) Cartilage histology (Osteochondral junction) Cartilage histology (Chondrocyte appearance) Cartilage histology (Subchondral bone structure) M. CG Vs. M. PRP Group Cartilage histology (Cartilage structure) Cartilage histology (Osteochondral junction) Cartilage histology (Chondrocyte appearance) Cartilage histology (Subchondral bone structure) | Qualitative Score Qualitative Score Qualitative Score Qualitative Score Qualitative Score Qualitative Score Qualitative Score Qualitative Score | = = = = = = = = | p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 p > 0.05 | N/A N/A N/A N/A N/A N/A N/A N/A |
Gamal et al. (2019) | Albino rat Wistar 15 ♂ 200–250 g 4–5 mo. | Cartilage defect surgical procedure | CG A* (5) CG B* (5) PRP Group (5) | 0.2 mL of PRP | 3x/wk. for 2 wk. | Molecular markers (PDGF-A levels) Cartilage histology (thickness) | Immunohistochemical analysis Qualitative analysis | + + | p < 0.05 p < 0.05 | 9.02 (−12.88 to −3.39) 33.81 (333.57 to 363.63) |
Guner & Buyukbebeci (2013) | Albino rat Wistar 20 ♂ 250–300 g Adult | Formalin injection | CG (10) PRP Group (10) | 0.05 mL of PRP | 1x/wk. for 3 wk. | Cartilage histology | Degeneration Score | = | p > 0.05 | N/A |
Hermeto et al. (2016) | Rabbit New Zealand 12 ♂ 3.5–4,5 kg Adult | Collagenase injection | CG (6) PRP Group (6) | Unclear | Unclear | Cartilage histology | Modified Mankin Score | = | p > 0.05 | −3.00 (−6.67 to −2.67) |
Jayaram et al. (2020) | Mice FVB/N 33 ♂ N/A 3 mo. | Destabilization of the Medial Meniscus | CG (10) LP-PRP Group (11) LR-PRP Group (12) | 0.005 mL of PRP | 3 injections | CG Vs. LP-PRP Group Cartilage histology Synovium histology CG Vs. LR-PRP Group Cartilage histology Synovium histology | OARSI Score Synovitis Score OARSI Score Synovitis Score | = = = = | p = 0.3157 p = 0.9999 p = 0.9999 p = 0.9999 | N/A (−23.96 to 3.66) N/A N/A (18.50 to 9.120) N/A |
Ji et al. (2015) | Rabbit New Zealand N/A ♀ N/A ♂ 1.75–2.75 kg 58 mo. | Modified Hulth Protocol | CG (10) PRP Group (11) | 0.5 mL of PRP | 1x/wk. for 5 wk. | Inflammatory markers (IL-1 levels) Inflammatory markers (IL-6 levels) Inflammatory markers (TNF-α levels) | ELISA ELISA ELISA | + + + | p < 0.05 p < 0.05 p < 0.05 | 0.64 (−1.50 to 0.26) 2.43 (−3.50 to −1.17) 3.24 (−4.47 to −1.76) |
Kanwat et al. (2017) | Guinea pig Dunkin-Hartley 24 ♂ 600–700 g N/A | Naturally occurring | CG A (6) CG B (6) PRP Group A (6) PRP Group B (6) | Unclear | 1x/wk. for 3 wk. | CG A Vs. PRP Group A Synovium histology Cartilage histology CG B Vs. PRP Group B Synovium histology Cartilage histology | Pelletier Score Modified Mankin Score Pelletier Score Modified Mankin Score | = + + + | p = 0.147 p = 0.002 p = 0.001 p = 0.0001 | −1.33 (−6.23 to −0.11) −2.45 (−1.76 to 1.08) −2.50 (−7.57 to −2.43) −3.00 (−9.91 to −3.09) |
Kutuk et al. (2014) | Rabbit New Zealand N/A 2.64–3 kg 12 mo. | Bilateral TMJ surgical procedure | CG (10) PRP Group (10) | 1 mL of PRP | Unclear | Cartilage histology (Fibrocartilage regeneration) Cartilage histology (Regeneration hyaline cartilage) | Quantitative analysis Quantitative analysis | = = | p = 0.143 p = 0.579 | N/A N/A |
Lu et al. (2020) | Rabbit New Zealand 17 ♀ 13 ♂ 3.0–4.5 kg ± 11 wk. | Modified Hulth Protocol | CG (15) PRP Group (15) | 0.5 mL of PRP | 1x/wk. for 10 wk. | Inflammatory markers (IL-1 levels) Inflammatory markers (IL-6 levels) Inflammatory markers (TNF-α levels) Cartilage histology | ELISA ELISA ELISA Mankin Score | + + + + | p < 0.01 p < 0.01 p < 0.01 p < 0.05 | −2.60 (−23.75 to −13.13) −4.50 (−54.56 to −39.00) −5.93 (−74.08 to −57.48) N/A |
Parlak & Arican (2020) | Dog Mixed breed 6 ♀ 30 ♂ 29–31 kg 4–6 yr. | Naturally occurring | CG (16) S. PRP Group (8) M. PRP Group (8) | Unclear | Single injection (S) 1x/wk. for 2 wk. (M) | Inflammatory markers (TNF-α levels) Inflammatory markers (IL-10 levels) Inflammatory markers (IL-6 levels) Inflammatory markers (IL-1β levels) | ELISA ELISA ELISA ELISA | = + + + | p > 0.05 p < 0.05 p < 0.05 p < 0.05 | N/A N/A N/A N/A |
Ragab et al. (2021) | Albino rat Wistar 20 ♂ 100–120 g 7–9 wk. | MIA injection | CG (10) PRP Group (10) | 0.05 mL of PRP | 1x/wk. for 3 wk. | Anti-inflammatory markers (IL-4 levels) Inflammatory markers (IL-17 levels) Inflammatory markers (TNF-α levels) | ELISA ELISA ELISA | + + + | p < 0.05 p < 0.05 p < 0.05 | N/A N/A N/A |
Wang et al. (2018) | Goat Boer 12 ♂ 40–50 kg 12–18 mo. | Anterior cruciate ligament transection and Medial Meniscectomy | CG (6) PRP Group (6) | 2 mL of PRP | 3x every 4 wk. | Inflammatory markers (IL-1β levels) Inflammatory markers (IL-6 levels) Inflammatory markers (TNF-α levels) Molecular markers (PGE2 levels) Cartilage histology | ELISA ELISA ELISA ELISA Pelletier Score | + = = + + | p < 0.05 p > 0.05 p > 0.05 p < 0.05 p < 0.05 | N/A N/A N/A N/A N/A |
Wu et al. (2016) | Rabbit New Zealand 32 ♀ 28 ♂ 2.5–3.0 kg 4–5 mo. | Modified Hulth Protocol | CG (15) PRP Group (15) | 0.5 mL of PRP | 1x/wk. for 6 wk. | Inflammatory markers (IL-1β levels in the joint fluid) Inflammatory markers (IL-1β levels in the serum) Inflammatory markers (IL-1β positive chondrocytes Inflammatory markers (Density of IL-1β staining) Cartilage histology Cartilage histology | ELISA ELISA Immunohistochemical analysis Immunohistochemical analysis Mankin Score Pelletier Score | + + + + + + | p = 0.0079 p = 0.0086 p = 0.0068 p = 0.0073 p = 0.0081 p < 0.05 | N/A N/A N/A N/A N/A N/A |
Xin et al. (2020) | Rat Sprague Dawley N/A 200–300 g 3–4 mo. | Anterior cruciate ligament transection | CG (5) PRP Group (5) | 0.05 mL of PRP | 1x/wk. for 4 wk. | Inflammatory markers (IL-1β levels) Inflammatory markers (IL-18 levels) Inflammatory markers (TNF-α levels) Molecular markers (Col2 levels) Cartilage histology Cartilage histology | ELISA ELISA ELISA ELISA Mankin Score OARSI Score | + + + + + + | p < 0.05 p < 0.05 p < 0.05 p < 0.05 p < 0.01 p < 0.01 | N/A N/A N/A N/A N/A N/A |
Yin et al. (2016) | Rabbit New Zealand 25 ♀ 25 ♂ 2.5–3.0 kg Adult | Anterior cruciate ligament transection | CG (10) PRP Group (10) | 3 mL of PRP | 1x/wk. for 3 wk. | Inflammatory markers (IL-1β levels) Molecular markers (PGE2 levels) | ELISA ELISA | + + | p < 0.05 p < 0.05 | N/A N/A |
Yun et al. (2016) | Dog Beagle 6 ♀ 30 ♂ 29–31 kg 4–6 yr. | Cranial cruciate ligament transection | CG (6) PRP Group (6) | 1 mL of PRP | 1x/wk. for 4 wk. | Femoral cartilage (TNF-α levels) Femoral cartilage (IL-1β + levels) Tibial cartilage (TNF-α levels) Tibial cartilage (IL-1β + levels) Femoral cartilage (Surface damage) Femoral cartilage (Hypocellularity) Femoral cartilage (Clone) Femoral cartilage (Stain intensity) Tibial cartilage (Surface damage) Tibial cartilage (Hypocellularity) Tibial cartilage (Clone) Tibial cartilage (Stain intensity) | Immunohistochemical analysis Immunohistochemical analysis Immunohistochemical analysis Immunohistochemical analysis Mankin Score Mankin Score Mankin Score Mankin Score Mankin Score Mankin Score Mankin Score Mankin Score | + + + + + + + + + + + + | p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01 p > 0.05 p > 0.05 p < 0.01 p > 0.05 p > 0.05 p > 0.05 | −6.29 (−115.62 to 76.38) −7.14 (−152.65 to 106.03) −2.83 (−134.09 to −50.25) −4.21 (−170.39 to −90.61) −3.44 (−2.29 to −1.05) −1.79 (−1.44 to −0.24) −0.77 (−1.33 to −0.33) −1.82 (−1.14 to −0.20) −3.44 (−2.29 to −1.05) −2.22 (−2.12 to −0.56) −0.57 (−1.07 to −0.41) −0.68 (−0.95 to −0.29) |